HIP
GILD icon

HUB Investment Partners’s Gilead Sciences GILD Stock Holding History

HUB Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Hold
100
– – ﹤0.01% 1375
2026
Q1 		$13.9K Buy
+100
New +$14K ﹤0.01% 1143

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

HUB Investment Partners's GILD Position: Q2 2026 in Review

HUB Investment Partners increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $1.38M and bringing the position to 87,005 shares worth $11M. The position accounts for 0.2% of the portfolio, ranked #94.

HUB Investment Partners first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HUB Investment Partners held 87,005 shares of Gilead Sciences worth $11M as of Q2 2026.
  • HUB Investment Partners bought 10,455 Gilead Sciences shares in Q2 2026, an estimated $1.38M.
  • Gilead Sciences made up 0.2% of HUB Investment Partners's portfolio in Q2 2026, its #94 holding.
  • HUB Investment Partners first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.